Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...

Severe temperature spikes may double or triple the risk of irregular heart rhythm in people with implanted defibrillators. An analysis of health data for more than 2,000 people with implantable ...

Jude ICD 1 Epic +VR (V-196) 2001 St. Jude CRT-ICD 1 Epic HF (V-337) 2004 St. Jude ICD 2 Epic +DR (V-239) 2002 Boston Scientific ICD 2 Vitality DS (T125) 2003 Boston Scientific ICD 1 Vitality 2 ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

This is due to their enhanced patient comfort and convenience compared to traditional pacemakers. Cardiac resynchronization therapy pacemakers (CRT-P) are expected to witness significant growth over ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates. The medical device maker's adjusted earnings per share and ...

Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be ...